Get addiction help now: (858) 838-4343

get help now

Get addiction help now: (858) 838-4343

get help now

Statement About MMT from NIDDK

Time to read: 2 min

From NIDDK Fact Sheet

Chronic Hepatitis C: Current Disease Management

“Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol or substance abuse. Typically a 6-month abstinence is recommended before starting therapy, but this should be applied only to patients with a history of alcohol abuse, not to social drinkers. Patients with continuing alcohol or substance abuse problems should only be treated in collaboration with alcohol or substance abuse specialists or counselors. Patients can be successfully treated while on methadone or in an active substance abuse program. Indeed, the rigor and regular monitoring that accompany methadone treatment provide a structured format for combination therapy. The dose of methadone may need to be modified during interferon-based therapy for hepatitis.”

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health under the U.S. Department of Health and Human Services.

From: NIH Publication No. 03-4230 February 2003

Similar Posts

AMTA’S Five-Year Plan for Methadone Treatment In the United States

ByAdmin
Admin 05/30/2023

AMTA’S Five-Year Plan for Methadone Treatment In the United States Presented at the Policy Makers Luncheon National Methadone Conference St. Louis, October 7-10, 2001 Accreditation (2001-2005) CSAT implemented new federal standards for accrediting methadone treatment programs on May 18, 2001. I submitted AMTA’s testimony in support of accreditation during my presentation to the Federal Interagency…

The National Methadone Conference-4

ByAdmin
Admin 01/16/2022

American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Hot Topic: Administrative Detox Facilitator: Joe Neuberger Delaware NAMA Bitch and Gripe.Com Administrative Detox is our subject. It is a policy whereby methadone patients in treatment are banished from their programs for the umbrella term of “non-compliance.” Now we’re not talking…

The Advocacy Training Session

ByAdmin
Admin 12/18/2021

  The first training for certification will include a variety of topics to give advocates a well-grounded understanding of methadone treatment, research, regulations and laws that protect methadone patients and programs.   Addiction and Methadone– Tom Payte, MD (Drug Dependence Associates) and Joycelyn Woods, MA. (NAMA) The biological constructs of addiction will be explained in…

Ombudsman Issue 3 & 4 Contents

ByAdmin
Admin 04/12/2021

Contents Note: These pages are, like the rest of our site, continually evolving. Non-working links will be activated shortly. Please report typos or errors to NAMA. Let’s Stop The Insanity by Anthony Scro Presidential Notes by Stan Novick The Editor’s Letter Methaphobia: Us and Them by Ira Sobel Stigma: The Invisible Barrier by Herman Joseph…

The History of Methadone Maintenance Treatment (Part One)

ByAdmin
Admin 03/25/2021

What is Methadone Maintenance Treatment? A) The most effective treatment for heroin and other opioid dependence? B) A means of reducing the transmission of the AIDS virus? C) The most progressive and misunderstood form of substance abuse treatment? D) All of the above? The answer is: D) All of the above Methadone maintenance treatment came…

The Award Banquet A historic occasion – the first time advocates are recognized for their work. Tuesday Evening, October 9th

ByAdmin
Admin 05/03/2021

Award Discussion At Joycelyn Wood’s table waiting for the Banquet to start Gary Nessenbaum, Judith Ostergard and Donna Schoen talk about the conference (l to r) The Nyswander -Dole Award Fondly called “The Marie” after Dr. Nyswander the Dole – Nyswander Award was first presented in 1983 to recognize extraordinary work in the field. Recipients…